Insider · CIK 0001871957
Michael A Klobuchar
Files at RVTY (REVVITY, INC.), EIKN (Eikon Therapeutics, Inc.). First filing -, latest -.
Michael A Klobuchar files SEC Form 4 as director and COO at RVTY (REVVITY, INC.), and also at EIKN (Eikon Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Michael A Klobuchar has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 7, 2026 | RVTY REVVITY, INC. | AGrant or award Common Stock | +1,015 | $0.00 | $0 | 6,103 | May 11, 2026 |
| May 7, 2026 | RVTY REVVITY, INC. | AGrant or award Common Stock | +1,265 | $0.00 | $0 | 7,368 | May 11, 2026 |
| Mar 2, 2026 | EIKN Eikon Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +87,157 | $0.00 | $0 | 87,157 | Mar 4, 2026 |
| Apr 30, 2025 | RVTY REVVITY, INC. | AGrant or award Common Stock | +1,074 | $0.00 | $0 | 3,750 | May 1, 2025 |
| Apr 30, 2025 | RVTY REVVITY, INC. | AGrant or award Common Stock | +1,338 | $0.00 | $0 | 5,088 | May 1, 2025 |
Questions about Michael A Klobuchar
Answered from the filings on this page, as of the latest one.
Is Michael A Klobuchar buying or selling?
Michael A Klobuchar has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Michael A Klobuchar's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael A Klobuchar has 0.
Where does Michael A Klobuchar file Form 4?
Michael A Klobuchar has filed Form 4 at RVTY (REVVITY, INC.); EIKN (Eikon Therapeutics, Inc.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.